Prostatic Stromal Sarcoma in an Adolescent: The Role of Chemotherapy | Zendy

Elena Cavaliere | Zendy; Rita Alaggio | Zendy; Marco Castagnetti | Zendy; Giovanni Scarzello | Zendy; Gianni Bisogno | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prostatic Stromal Sarcoma in an Adolescent: The Role of Chemotherapy

Author(s) -

Elena Cavaliere,

Rita Alaggio,

Marco Castagnetti,

Giovanni Scarzello,

Gianni Bisogno

Publication year - 2014

Publication title -

rare tumors

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.285

H-Index - 15

eISSN - 2036-3613

pISSN - 2036-3605

DOI - 10.4081/rt.2014.5607

Subject(s) - medicine , chemotherapy , ifosfamide , vincristine , doxorubicin , sarcoma , stromal tumor , oncology , stromal cell , pathology , cyclophosphamide , cisplatin

Prostatic stromal sarcoma (PSS) is a rare tumor that normally occurs in adult age. Its management relies mainly on surgery. We report the first case of PSS occurring in an adolescent. There was evidence of a good response to chemotherapy including ifosfamide, doxorubicin, vincristine and actinomycin-D, although the final outcome was dismal. A review of the English literature revealed 14 additional patients with PSS treated with chemotherapy: tumor shrinkage was reported in 4 of the 6 evaluable patients. Patients with PSS may benefit from the use of chemotherapy in combination with early aggressive local treatment

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research